Parkinson's Disease Clinical Trial
Verified date | January 2014 |
Source | Chang Gung University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Taiwan: Department of Health |
Study type | Interventional |
Parkinson's disease (PD) is a progressive degenerative disease of central nervous systems
deficit. The clinical symptoms of Parkinson's disease include the following motor tasks:
difficult in initiating movement, performing rhythmic movement or serial movement, the
ability of learning motor movement is also affected. The primary treatment for Parkinson's
disease is medical treatment; surgery is used if in need. Rehabilitation such as physical
therapy, which aims to improve patient's quality of life and functions, is a non-invasive
treatment and value for PD patients. Auditory cue is a technique that widely applied on
training patients with Parkinson's disease, and some researches revealed that auditory
cueing could improve motor performance. However, the mechanism under this treatment
technique is still unknown.
This study is to investigate the effect of auditory cueing on rhythmic finger movement in
patients with Parkinson's disease. To investigate the mechanism under auditory cueing,
neurophysiological data such as motor cortex excitability and blood flow in cortical cortex
will be obtained by using Transcranial magnetic stimulation (TMS) and near infrared
spectroscopy (NIRS).
Status | Recruiting |
Enrollment | 38 |
Est. completion date | August 2014 |
Est. primary completion date | August 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 20 Years and older |
Eligibility |
Inclusion Criteria: - Clinical diagnosis of Parkinson disease Exclusion Criteria: - Clinical diagnosis of other neurological diseases - Dementia - Been diagnosed with any mental illness - History of seizures - Brain trauma - Body with a pacemaker or other electrical stimulator - Pregnancy |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Taiwan | Chang Gung University | Taoyuan |
Lead Sponsor | Collaborator |
---|---|
Chang Gung University |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Finger Tapping | Record pre-test and post-test change. | Baseline,45-60 minutes. | No |
Primary | Motor evoked potential | Use single-pulse TMS to assess Motor evoked potential change. | Baseline,45-60 minute | No |
Primary | Intracortical inhibition & Intracortical facilitation | Use paired-pulse TMS to record pre-test and post-test change. | Baseline,45-60 minutes | No |
Primary | Blood oxygen dependent level | Use Near-infrared spectroscopy to record pre-test, in experiment, and post-test change. | Baseline, in experiment,45-60 minutes | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Terminated |
NCT02924194 -
Deep Brain Stimulation of the nbM to Treat Mild Cognitive Impairment in Parkinson's Disease
|
N/A | |
Completed |
NCT02927691 -
Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial
|
Phase 2 |